| Publication Number | Title | Priority Date |
|---|---|---|
| CN-115260442-A | A kind of fast self-healing thermoplastic polyurethane elastomer material and preparation method thereof | 2022-08-28 |
| CN-115287065-A | A kind of preparation method and application of nitrogen and phosphorus co-doped carbon dots | 2022-08-09 |
| CN-115184486-A | A kind of method for detecting diaminopyridine phosphate related substances by high performance liquid chromatography | 2022-06-27 |
| CN-114712321-A | Diaminopyridine phosphate sustained-release tablet and preparation method thereof | 2022-04-22 |
| CN-114682104-A | A kind of perovskite type conductive ceramic film and its preparation method and application | 2022-03-30 |
| CN-114517051-A | Aqueous polyurethane-urea dispersion, preparation method and application thereof | 2022-03-02 |
| CN-114426981-A | African swine fever virus antigen protein recombinant expression vector, recombinant plant lactic acid bacteria and preparation method and application thereof | 2022-02-21 |
| CN-114426981-B | African swine fever virus antigen protein recombinant expression vector, recombinant plant lactic acid bacteria and its preparation method and application | 2022-02-21 |
| CN-114371158-A | Preparation method of hydrogel kit for monitoring degradation of organophosphorus pesticide | 2022-01-29 |
| CN-114349758-A | Compound with pyridine imidazole as parent nucleus and preparation method and application thereof | 2022-01-21 |
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 28641995 | 2017-07-01 | Acetylator Status Impacts Amifampridine Phosphate (Firdapse™) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function | Clinical therapeutics |
| 26852139 | 2016-05-01 | Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMS | Muscle & nerve |
| 26101174 | 2015-07-01 | Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults | Clinical therapeutics |
| 25015919 | 2014-08-15 | Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist | The Journal of physiology |
| 22922120 | 2012-12-06 | Ectopic uterine tissue as a chronic pain generator | Neuroscience |
| 22841859 | 2012-11-01 | Reversal of BoNT/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations | Neurochemistry international |
| 22742743 | 2012-07-13 | Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates | American journal of human genetics |
| 22805230 | 2012-07-01 | The use of aminopyridines in neurological disorders | Clinical neuropharmacology |
| 22497693 | 2012-05-01 | The safety profile of dalfampridine extended release in multiple sclerosis clinical trials | Clinical therapeutics |
| 22409941 | 2012-04-01 | 3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis | Journal of neuroimmunology |
